Molekule to preview pre-clinical allergen trial results at AAAAI annual meeting

Molekule Group will showcase new research findings at the 2023 American Academy of Allergy, Asthma, and Immunology, AAAAI, Annual Meeting. Gathering researchers and experts in allergies, asthma, and immunology, the AAAAI Annual Meeting will take place February 24-27 at the Henry B. Gonzalez Convention Center in San Antonio, Texas. "Indoor air quality is of the utmost importance to patients worldwide," stated Gregory Bensch, M.D., President of Allergy, Asthma, and Immunology Medical Group. "Molekule’s recent study demonstrates that even undetectable amounts of allergens can precipitate type 2 inflammation that drives rhinitis and asthma in many patients. In this study model, PECO technology demonstrated the ability to reduce allergens to levels that are not only undetectable, but can prevent this inflammatory response."